KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

LifeMD (LFMD) EBIAT (2016 - 2025)

LifeMD's EBIAT history spans 14 years, with the latest figure at $20.0 million for Q4 2025.

  • For Q4 2025, EBIAT rose 397.74% year-over-year to $20.0 million; the TTM value through Dec 2025 reached $17.0 million, up 173.94%, while the annual FY2025 figure was $14.4 million, 161.94% up from the prior year.
  • EBIAT reached $20.0 million in Q4 2025 per LFMD's latest filing, up from -$3.8 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $20.0 million in Q4 2025 to a low of -$18.0 million in Q4 2021.
  • Average EBIAT over 5 years is -$6.6 million, with a median of -$6.3 million recorded in 2023.
  • Peak YoY movement for EBIAT: tumbled 393.98% in 2021, then skyrocketed 397.74% in 2025.
  • A 5-year view of EBIAT shows it stood at -$18.0 million in 2021, then skyrocketed by 33.72% to -$11.9 million in 2022, then soared by 68.73% to -$3.7 million in 2023, then tumbled by 79.66% to -$6.7 million in 2024, then surged by 397.74% to $20.0 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's EBIAT are $20.0 million (Q4 2025), -$3.8 million (Q3 2025), and -$1.1 million (Q2 2025).